Literature DB >> 6778637

Compositional changes of urinary acidic glycosaminoglycans in progressive systemic sclerosis.

K Murata, M Takeda.   

Abstract

The compositional changes of acidic glycosaminoglycans (AGAG) in the urine of progressive systemic sclerosis (PSS) patients were studied using chondroitinases and heparitinase in appropriate enzyme assays and by electrophoretic characterization. Daily urinary excretion of AGAG in patients with PSS was increased, when compared to normals. The proportion of urinary AGAG in PSS patients, which was undigested by chondroitinase-ABC (most probably representing heparan sulfates (HS)), increased significantly from the normal value. The substance was found to be mainly HS as determined by the electrophoretic pattern, thin-layer chromatographic analysis and by its susceptibility to heparitinase. After digestion of urinary chondroitin sulfate isomers with chondroitinases, the unsaturated disaccharides were mainly separated into 4-sulfated and 6-sulfated disaccharide units by paper chromatography. In all of the patients with PSS, the ratio of the unsaturated 4-sulfated disaccharide to the unsaturated disaccharide was higher than that in normal subjects. These observations indicate an abnormal turnover of AGAG in patients with PSS.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6778637     DOI: 10.1016/0009-8981(80)90291-0

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Hyaluronic acid is increased in the skin and urine in patients with amyotrophic lateral sclerosis.

Authors:  S Ono; T Imai; M Yamauchi; K Nagao
Journal:  J Neurol       Date:  1996-10       Impact factor: 4.849

2.  Urinary acidic glycosaminoglycans in Werner's syndrome.

Authors:  K Murata
Journal:  Experientia       Date:  1982-03-15

3.  Comparison of urinary glycosaminoglycan excretion in rheumatoid arthritis, osteoarthritis, myocardial infarction, and controls.

Authors:  A J Chuck; J Murphy; J B Weiss; D M Grennan
Journal:  Ann Rheum Dis       Date:  1986-02       Impact factor: 19.103

4.  HDACi mediate UNG2 depletion, dysregulated genomic uracil and altered expression of oncoproteins and tumor suppressors in B- and T-cell lines.

Authors:  Tobias S Iveland; Lars Hagen; Animesh Sharma; Mirta M L Sousa; Antonio Sarno; Kristian Lied Wollen; Nina Beate Liabakk; Geir Slupphaug
Journal:  J Transl Med       Date:  2020-04-07       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.